74 managers (76 13F filers) reported a position in PYXS shares at 2026-06-30, 34,152,124 shares in all. 9 filers opened a position and 10 filers sold out during the quarter.
Managers
74
13F filers
76
New
9
Added
24
Reduced
24
Sold out
10
Shares held by filers
34,152,124
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
No Form 4 transaction on this security in the data.
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
ORBIMED ADVISORS LLC and 1 other reporting person reported 4,348,197 PYXS shares, 3.6% of the class, as of 2026-09-30, in a 13G filed 2026-11-16. 0000947871-26-001035
Accepted , ingested
BIOTECHNOLOGY VALUE FUND L P and 9 other reporting persons reported 11,945,583 PYXS shares, 9.99% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0000921895-26-003186
Accepted , ingested
RTW INVESTMENTS, LP and 1 other reporting person reported 8,535,153 PYXS shares, 9.9% of the class, as of 2026-09-30, in a 13G filed 2026-11-16. 0001493215-26-000202
Accepted , ingested
Laurion Capital Management LP and 2 other reporting persons reported 4,300,888 PYXS shares, 5.16% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-03. 0001390202-26-000019
Accepted , ingested
GordonMD Global Investments LP and 3 other reporting persons reported 20,441,948 PYXS shares, 16.4% of the class, as of 2026-10-01, in a 13G/A filed 2026-10-09. 0000919574-26-006818
Accepted , ingested
Coastlands Capital LP and 4 other reporting persons reported 6,448,907 PYXS shares, 5.42% of the class, as of 2026-10-01, in a 13G filed 2026-10-05. 0001104659-26-113597
Accepted , ingested
GordonMD Global Investments LP and 3 other reporting persons reported 27,988,714 PYXS shares, 17.5% of the class, as of 2026-10-01, in a 13G/A filed 2026-10-02. 0000919574-26-006608